🔎 Trials Near Me

Početna › Ewingov sarkom › Texas › Houston

Kliničke studije za Ewingov sarkom u gradu Houston, TX

7 studija za Ewingov sarkom traži sudionike na lokacijama u gradu Houston i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.

Službeni tekst studije (engleski)

Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)

U tijeku regrutacijaFaza 1
  • University of Texas MD Anderson Cancer Center, Houston
Od 2 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT07297979

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

U tijeku regrutacijaFaza 1/2
  • University of Texas MD Anderson Cancer Center ( Site 1007), Houston
6 Months – 25 Years · Oba spola · Ažurirano 17. ruj 2026. · NCT06395103

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

U tijeku regrutacijaFaza 1
  • UT MD Anderson Cancer Center, Houston
Od 12 do 85 godina · Oba spola · Ažurirano 8. ruj 2026. · NCT03715933

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

U tijeku regrutacijaFaza 1/2
  • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
12 Months – 30 Years · Oba spola · Ažurirano 25. kol 2026. · NCT04851119

A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies

U tijeku regrutacijaFaza 1
  • The University of Texas MD Anderson Cancer Center, Houston
Od 16 godina i više · Oba spola · Ažurirano 2. lip 2026. · NCT07197554

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

U tijeku regrutacijaFaza 1/2
  • The University of Texas MD Anderson Cancer Center, Houston
Od 2 do 30 godina · Oba spola · Ažurirano 3. velj 2026. · NCT05734066

HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma

U tijeku regrutacijaFaza 1
  • Texas Children's Hospital, Houston
Od 1 do 25 godina · Oba spola · Ažurirano 22. sij 2026. · NCT04995003

Studije za Ewingov sarkom u drugim gradovima

Ostale studije u gradu Houston

Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.